Drug-eluting coronary stents: faith and hope, but no charity
- A Randomized Study Assessing the Effects of Pretreatment with Cilostazol on Periprocedural Myonecrosis after Percutaneous Coronary Intervention. Kim, Byeong-Keuk; Oh, Seung Jin; Yoon, Se-Jung; Jeon, Dong Woon; Ko, Young-Guk; Yang, Joo Young // Yonsei Medical Journal;9/1/2011, Vol. 52 Issue 5, p717
Purpose: It is unknown whether cilostazol pretreatment reduces postprocedural myonecrosis (PPMN). Cilostazol pretreatment reduces PPMN after percutaneous coronary intervention (PCI). Materials and Methods: A total of 120 patients with stable angina scheduled for elective PCI were randomly...
- Role of stenting in coronary revascularisation. Gershlick, Anthony H. // Heart;Jul2001, Vol. 86 Issue 1, p104
Percutaneous treatment for atheromatous coronary disease has developed rapidly in the last 5-10 years. Some technologies, such as laser therapy, have fallen by the wayside as clinical trials and clinical experience demonstrates lack of efficacy or excess complications. Others devices such as...
- CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION WITH STENT KISSING BALLOON (SKB) TECHNIQUE IN OSTIAL LAD LESIONS. // Heart;Oct2010, pA110
An abstract of the article "Clinical Outcomes of Percutaneous Coronary Intervention With Stent Kissing Balloon (SKB) Technique in Ostial Lesions" by Chen Jilin and colleagues is presented.
- Angiographic luminal loss in porcine coronary arteries is reduced by stent_based adenovirus_mediated antagonism of TGF_Î²1 // Molecular Therapy;May2004 Supplement 1, Vol. 9, p79
An abstract of the article "Angiographic Luminal Loss in Porcine Coronary Arteries Is Reduced by Stent-Based Adenovirus-Mediated Antagonism of TGF-Î²1," by Clare E. Appleby, Paul A. Kingston, Michel Verhoeven, Anita Driessen and Anthony M. Heagerty is presented.
- Drug-eluting stents or coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observational studies. Qing Li; Zhi Zhang; Rui-Xing Yin // Trials;2013, Vol. 14 Issue 1, p1
Background: The clinical application of drug-eluting stents (DES) or coronary artery bypass grafting (CABG) for unprotected left main coronary artery disease (ULMCAD) is still controversial. The purpose of this meta-analysis was to compare the safety and efficacy between DES and CABG for ULMCAD....
- Brachytherapy for In-Stent Restenosis. Mukherjee, Debabrata; Moliterno, David J. // JAMA: Journal of the American Medical Association;3/15/2006, Vol. 295 Issue 11, p1307
The editorial focuses on target vessel revascularization (TVR) and in-stent restenosis (ISR). The results of clinical trials, such as TAXUS V ISR whose patients had paclitaxel-eluting stents and Sirolimus-Eluting Stent with Vascular Brachytherapy for the Treatment of In-Stent Restonisis (SISR),...
- Medtronic initiates landmark drug-eluting balloon study. Pedersen, Amanda // Medical Device Daily;4/16/2012, Vol. 16 Issue 73, p1
The article reports on the study initiated by Medtronic for its line of In.Pact drug-eluting balloons to treat peripheral artery disease (PAD) in the superficial femoral artery and/or proximal popliteal artery. Medtronic spokesman Joe McGrath points out the problems associated with standard...
- Platelet reactivity and clinical outcomes after coronary stenting. // Reactions Weekly;8/3/2013, Issue 1464, p4
The article focuses on the study which explored the platelet reactivity and clinical outcomes of patients with coronary artery disease following coronary stenting.
- Accordion effect in a thin-strut coronary stent. Aung, Sm; Demir, As; Boztosun, B // Perfusion;Sep2012, Vol. 27 Issue 5, p435
Longitudinal compression (accordion effect) of modern thinner-strut stents has been recently recognised. We report a typical case of longitudinal stent compression caused by a post-dilatation balloon.